Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 5.10
-0.07 (-1.35%)
Jun 12, 2026, 5:05 PM CET
Mendus AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
312.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 3.00M | 2.99M | 49,816.67% |
| Dec 31, 2021 | 6.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.21M |
| Sprint Bioscience AB | 153.28M |
| Xbrane Biopharma AB | 76.45M |
| Nanologica AB | 31.83M |
| Intervacc AB | 18.89M |
| Corline Biomedical AB | 10.67M |
| Diamyd Medical AB | 362.00K |
Mendus AB News
- 5 weeks ago - Mendus AB Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Mendus AB Quarterly report: Q1 2026 - Filings
- 2 months ago - Mendus AB Slides: Corporate presentation - Filings
- 4 months ago - Mendus AB Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - Mendus AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Mendus AB Slides: Q4 2025 - Filings
- 4 months ago - Mendus AB Annual report: Q4 2025 - Filings
- 7 months ago - Mendus AB Earnings Call Transcript: Q3 2025 - Transcripts